Bactobio

company

About

Bactobio is a biotechnology company thats focused on harvesting metabolites from biological dark matter.

Details

Last Funding Type
Funding Round
Last Funding Money Raised
£6M
Industries
Biotechnology
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Bactobio Ltd
Also Known As
Baccuico

Bactobio uses breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to harvest novel microbes and screen them for medical and industrial applications.

It aims to help solve the antibiotic resistance crisis by discovering novel antibiotic classes targeting some of the most urgent bacterial pathogens - before moving on to broader applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£6M $5.30M
Bactobio has raised a total of £6M $5.30M in funding over 2 rounds. Their latest funding was raised on Dec 5, 2022 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 5, 2022 Funding Round £6M 3 Bridford Group Detail
Oct 6, 2021 Seed $3.80M 5 Detail
Nov 11, 2020 Seed $1.50M Detail

Investors

Number of Lead Investors
Number of Investors
1
6
Bactobio is funded by 6 investors. Bridford Group and Hugh Grant are the most recent investors.
Investor Name Lead Investor Funding Round
Bridford Group Yes Funding Round
Hugh Grant Funding Round
Peder Nielsen Funding Round
Claudio Costamagna Seed
Jonathan Milner Seed
Leopoldo Zambeletti Seed

Employee Profiles

Number of Employee Profiles
2
Bactobio has 2 current employee profiles, including Executive Daniel Blicher Holst Hansen